• About Us
    • Fact Checking Policy
    • Ownership & funding information
  • Volunteer
    • Internship with The Online Citizen
  • Donation
  • Subscription
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

COVID-19 vaccine: Russia’s hastened vaccine trial sparks controversy, Indonesia commences clinical trial of China-made vaccine, UK partners with Novavax

by The Online Citizen
16/08/2020
in Current Affairs, Health
Reading Time: 3 mins read
9

The world is anticipating the availability of a suitable COVID-19 vaccine soon as researchers and pharmaceutical companies are busy developing vaccines for the deadly virus that has infected more than 20 million globally.

As of last month, there had been 24 clinical trials and 142 pre-clinical trials on the COVID-19 vaccines worldwide.

There are six types of vaccine designs being developed around the world: Non-activated virus vaccine, subunit protein vaccine, virus-like particle (VLP), weakened live virus, DNA vaccine, and vector vaccine.

Many countries cast doubt over Russia-produced COVID-19 vaccine

Russia President Vladimir Putin on 11 August announced that Russia was the first country in the world that approves the COVID-19 vaccine regulation.

The incumbent leader also claimed that the vaccines produced by Gamaleya Research Institute of Epidemiology and Microbiology in Moscow had gained approval for use. Officials also said that Russia would start mass vaccination in October.

The official statement sparked protests from the world’s scientific community as final clinical trials on the vaccines have yet to be concluded. Russia has also not published the result of the first clinical trial.

The World Health Organization (WHO) stated that its approval will necessitate a thorough data review regarding its safety.

“We are in close contact with the Russian health authorities and discussions are ongoing concerning possible WHO pre-qualification of the vaccine,” said the United Nations’ health agency’s spokesman Tarik Jasarevic.

Indonesia prioritised for COVID-19 vaccine access from China

Indonesia is said to be prioritised for access to a China-made COVID-19 vaccine — the country will be participating in the final clinical trial of vaccine candidates from Sinovac Biotech on humans.

Head of Clinical Trial at Indonesia’s state-owned pharmaceutical company Bio Farma Rini Mulia Sari told Kompas on 12 August that there would be a technology transfer, meaning the vaccines sold in Indonesia would be produced by the company.

Sinovac is also conducting a clinical trial in other countries such as Bangladesh and Brazil.

Indonesia is also partnering with potential vaccine-producing countries such as South Korea and the United Arab Emirates.

Novavax signs a deal with the British government

The UK announced that it will be ordering 60 million doses of COVID-19 vaccines from the US-based pharmaceutical firm Novavax for the third phase of the clinical trial.

“We are honoured to partner with the UK government to deliver a vaccine that could provide vital protection in the fight against the global health crisis,” said Stanley C. Erck, President and Chief Executive Officer of Novavax in a statement on Friday (14 August).

The company stated that it would supply dosages of NVX-CoV2372 to the UK starting the first quarter of next year. In comparison, the Phase 2 trial is expected to resume in the third quarter.

Mr Erck added that the Phase 3 trial in the UK is the most crucial part of assessing the efficacy of the COVID-19 vaccine NVX-CoV2373.

The Phase 1 trial showed a satisfactory result as the vaccine could evoke antibody responses.

Additionally, Novavax is partnering with global pharmaceutical firm FUJIFILM Diosynth Biotechnologies to produce its antigen at the UK site.

Share this:

  • Twitter
  • Facebook
Tags: COVID-19Indonesia
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
9 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Recent Posts

  • 32 new cases of COVID-19 infection in S’pore; One new community case
  • No news of investigation into allegations against PAP Ivan Lim 9 months after GE
  • Heng Swee Keat too old at 60 to be PM but PM Lee, pushing 70 is not too old to stay on indefinitely?
  • From “deeply honored” by PM Lee’s and Cabinet colleagues’ trust to “too short a runway” in 2 years
  • PAP’s failed succession plan; Is there more that meets the eye?
  • Myanmar military waging nationwide offensives to crush ethnic support for anti-coup resistance 
  • UK PM hails Philip’s ‘extraordinary life’ as tributes pour in
  • Queen Elizabeth II’s husband Prince Philip dies aged 99

Trending posts

33-year old SAF male regular found dead in Kranji Camp II

PAP’s failed succession plan; Is there more that meets the eye?

Heng Swee Keat too old at 60 to be PM but PM Lee, pushing 70 is not too old to stay on indefinitely?

Chan echoes PM Lee assuring that same team still in place despite Heng stepping aside as 4G leader

Heng Swee Keat throws in the towel as touted successor to Singapore premiership

Progress Singapore Party voices concern over stepping down of DPM Heng as designated PM successor

No news of investigation into allegations against PAP Ivan Lim 9 months after GE

Over S$45,000 raised by Roy Ngerng in two days to pay for defamation damages to Lee Hsien Loong

The Court of Public Opinion took 11 Days while the Courts of Law took over 2 years

Roy Ngerng starts fundraising to pay PM Lee for his outstanding defamation damages; Over S$12,000 raised in a day

Load More
August 2020
MTWTFSS
 12
3456789
10111213141516
17181920212223
24252627282930
31 
« Jul   Sep »
  • About Us
  • Volunteer
  • Donation
  • Subscription
  • Letter submission
  • Contact Us

© 2006 - 2021 The Online Citizen

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2006 - 2021 The Online Citizen

wpDiscuz
9
0
Would love your thoughts, please comment.x
()
x
| Reply